| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6247066 | Transplantation Proceedings | 2016 | 6 Pages |
Abstract
The risk of GVHD appears to be increased in recipients of multivisceral transplantations who received chemotherapy due to an underlying malignancy. The reasons may be the large amount of lymphoid tissue in these types of grafts, and the cytotoxic effects of the malignancy and chemotherapy on healthy recipient tissues. These patients should be monitored closely for the development of GVHD.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
J. Cromvik, J. Varkey, G. Herlenius, J.-E. Johansson, C. Wennerås,